In addition, the MEK/ERK pathway enhances proliferation and inhibits apoptosis in HepG2 cells [14] and promotes the development of hepatocellular carcinoma in vivo [15]. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.